These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. The as-needed treatment strategy for choroidal neovascularization: a feedback-based treatment system. Spaide RF Am J Ophthalmol; 2009 Jul; 148(1):1-3. PubMed ID: 19540983 [No Abstract] [Full Text] [Related]
47. Rapid progression of subclinical age-related macular degeneration in the untreated fellow eye after intravitreal bevacizumab. Yoon YH; Kim JG; Chung H; Lee SY Acta Ophthalmol; 2009 Sep; 87(6):685-7. PubMed ID: 18705680 [No Abstract] [Full Text] [Related]
48. Photodynamic therapy with verteporfin combined with intravitreal injection of bevacizumab for exudative age-related macular degeneration. Aggio FB; Melo GB; Höfling-Lima AL; Eid Farah M Acta Ophthalmol Scand; 2006 Dec; 84(6):831-3. PubMed ID: 17083553 [No Abstract] [Full Text] [Related]
49. Bevacizumab for occult subfoveal neovascularization in age-related macular degeneration. Jonas JB; Harder B; Spandau UH; Kamppeter BA; Libondi T; Sauder G Eur J Ophthalmol; 2006; 16(5):774-5. PubMed ID: 17061237 [TBL] [Abstract][Full Text] [Related]
50. Intravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhage. Stifter E; Michels S; Prager F; Georgopoulos M; Polak K; Hirn C; Schmidt-Erfurth U Am J Ophthalmol; 2007 Dec; 144(6):886-892. PubMed ID: 17916314 [TBL] [Abstract][Full Text] [Related]
51. Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration. Ahmadieh H; Taei R; Soheilian M; Riazi-Esfahani M; Karkhaneh R; Lashay A; Azarmina M; Dehghan MH; Moradian S BMC Ophthalmol; 2007 Jun; 7():10. PubMed ID: 17555600 [TBL] [Abstract][Full Text] [Related]
52. Intravitreal bevacizumab for myopic choroidal neovascularization. Rensch F; Spandau UH; Schlichtenbrede F; von Baltz S; Libondi T; Jonas JB; Vossmerbaeumer U Ophthalmic Surg Lasers Imaging; 2008; 39(3):182-5. PubMed ID: 18556936 [TBL] [Abstract][Full Text] [Related]
53. Intravitreal use of bevacizumab (Avastin) for choroidal neovascularization due to ARMD: a preliminary multifocal-ERG and OCT study. Multifocal-ERG after use of bevacizumab in ARMD. Moschos MM; Brouzas D; Apostolopoulos M; Koutsandrea C; Loukianou E; Moschos M Doc Ophthalmol; 2007 Jan; 114(1):37-44. PubMed ID: 17216267 [TBL] [Abstract][Full Text] [Related]
54. Intravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitis. Tran TH; Fardeau C; Terrada C; Ducos De Lahitte G; Bodaghi B; Lehoang P Graefes Arch Clin Exp Ophthalmol; 2008 Dec; 246(12):1685-92. PubMed ID: 18682970 [TBL] [Abstract][Full Text] [Related]